Rosetta Genomics Ltd. - Ordinar ROSG
Set alert
0.43 0.00 0.00%
At close · Jun 28
0.42 Day range 0.44
0.23 52-week range 2.82
- YTD
- -100.00%
- 1 year
- -100.00%
- Open
- 0.43
- Prev close
- 0.43
- Mkt cap
- 2.07M
- Vol
- 169.60K
- Avg vol
- 104.81K
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.42
- High
- 0.44
- Forward P/E
- -0.09
- Beta
- 0.64
- Short ratio
- 1.54
- Inst. own
- 14.42%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.398
- 200-d avg
- 0.594118
- 1y target
- 24.00
Analyst view
Consensus: buy
Buy
Price target (mean) 24.00
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | 0.00 | 0.00 – 0.00 | -2.40 | 0.0% | 3.70M | +42.1% | 0 |
| Next quarter | 0.00 | 0.00 – 0.00 | -1.92 | 0.0% | 4.00M | +65.8% | 0 |
| Current year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 12.91M | +39.8% | 0 |
| Next year | 0.00 | 0.00 – 0.00 | 0.00 | 0.0% | 18.10M | +40.2% | 0 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Dec 17, 2017 | Barrington Research | Downgrade | Outperform | Market Perform |
| Jan 7, 2016 | Aegis Capital | Initiated | — | Buy |
| Apr 29, 2015 | Barrington Research | Initiated | — | Outperform |
| Apr 16, 2015 | Cantor Fitzgerald | Upgrade | — | Buy |
| Jun 3, 2014 | Barrington Research | Initiated | — | Outperform |
| Oct 29, 2013 | Aegis Capital | Downgrade | — | Hold |
| Apr 11, 2013 | Sidoti & Co. | Downgrade | — | Neutral |
| Aug 22, 2012 | Aegis Capital | Initiated | — | Buy |